1. Mendez MF, Cummings JL. Dementia: a clinical approach. 3rd ed. Philadelphia, Penn: Butterworth-Heinemann;2003.
2. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010; 362:329–344.
3. Van Hoesen GW, Hyman BT. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res. 1990; 83:445–457.
4. Lee YW, Cho IS, Kim HS. Comparison in care burden, fatigue, and life contentment of caregivers by gender relationship with demented elders. Korean J Women Health Nurs. 2009; 15:196–204.
5. Park KW, Kim SY, Kim EG, Kim JW, Kim TY, Sung SM, et al. Factors affecting depression and life satisfaction in family caregivers of patients with dementia. J Korean Neurol Assoc. 2005; 23:776–783.
6. Kim TY, Kim SY, Kim JW, Kim EG, Park KW, Sung SM, et al. The difference of caregiver burden in patients with Alzheimer's disease and vascular dementia. J Korean Neurol Assoc. 2005; 23:463–470.
7. Hirano A, Suzuki Y, Kuzuya M, Onishi J, Hasegawa J, Ban N, Umegaki H. Association between the caregiver's burden and physical activity in community-dwelling caregivers of dementia patients. Arch Gerontol Geriatr. 2011; 52:295–298.
8. Atchison TB, Massman PJ, Doody RS. Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer's type. Arch Clin Neuropsychol. 2007; 22:99–107.
9. Wang PN, Liu HC, Lirng JF, Lin KN, Wu ZA. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment. Psychiatry Res. 2009; 171:221–231.
10. Rusinek H, Endo Y, De Santi S, Frid D, Tsui WH, Segal S, et al. Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology. 2004; 63:2354–2359.
11. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry. 2002; 72:491–497.
12. Dickerson BC, Salat DH, Bates JF, Atiya M, Killiany RJ, Greve DN, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol. 2004; 56:27–35.
13. Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology. 2000; 55:484–489.
14. Wang PN, Lirng JF, Lin KN, Chang FC, Liu HC. Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan. Neurobiol Aging. 2006; 27:1797–1806.
15. Suh GH, Ju YS, Yeon BK, Shah A. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline. Int J Geriatr Psychiatry. 2004; 19:817–824.
16. Risacher SL, Saykin AJ, West JD, Shen L, Firpi HA, McDonald BC. Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr Alzheimer Res. 2009; 6:347–361.
17. Marcos A, Gil P, Barabash A, Rodriquez R, Encinas M, Fernandez C, et al. Neuropsychological markers of progression from mild cognitive impairment to Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2006; 21:189–196.
18. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999; 52:1397–1403.
19. Choi SH, Na DL, Kwon HM, Yoon SJ, Jeong JH, Ha CK. The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients. J Korean Med Sci. 2000; 15:609–615.
20. Ku HM, Kim JH, Kwon EJ, Kim SH, Lee HS, Ko HJ, et al. A study on the reliability and validity of Seoul-instrumental activities of daily living (S-IADL). J Korean Neuropsychiatr Assoc. 2004; 43:189–199.
21. Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci. 2010; 25:1071–1076.
22. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology. 2004; 62:591–600.
23. Kim GH, Kwon HJ, Go SA, Kim JE, Park KD, Choi KG, et al. T1-Axial medial temporal atrophy visual rating: a comparable study with Schelten's T1-coronal visual rating. Dement Neurocogn Disord. 2009; 8:37–44.
24. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987; 149:351–356.
25. Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, et al. Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimers Dement. 2011; 7:579–592.
26. Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, et al. Donepezil MSAD Study Investigators Group. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geriatr Soc. 2003; 51:737–744.
27. Park HK, Na DL, Han SH, Kim JY, Cheong HK, Kim SY, et al. Clinical characteristics of a nationwide hospital-based registry of mild-to-moderate Alzheimer's disease patients in Korea: a CREDOS (Clinical Research Center for Dementia of South Korea) study. J Korean Med Sci. 2011; 26:1219–1226.
28. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994; 271:1004–1010.
29. Monaci L, Morris RG. Neuropsychological screening performance and the association with activities of daily living and instrumental activities of daily living in dementia: baseline and 18- to 24-month follow-up. Int J Geriatr Psychiatry. 2012; 27:197–204.
30. Razani J, Casas R, Wong JT, Lu P, Alessi C, Josephson K. Relationship between executive functioning and activities of daily living in patients with relatively mild dementia. Appl Neuropsychol. 2007; 14:208–214.
31. Yang Y, Yang HD, Hong YJ, Kim JE, Park MH, Na HR, et al. Activities of daily living and dementia. Dement Neurocogn Disord. 2012; 11:29–37.
32. Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease. Biol Psychiatry. 2008; 64:871–879.